BRPI0509585A - preparação farmacêutica para a aplicação na pele com um teor de drospirenona - Google Patents

preparação farmacêutica para a aplicação na pele com um teor de drospirenona

Info

Publication number
BRPI0509585A
BRPI0509585A BRPI0509585-9A BRPI0509585A BRPI0509585A BR PI0509585 A BRPI0509585 A BR PI0509585A BR PI0509585 A BRPI0509585 A BR PI0509585A BR PI0509585 A BRPI0509585 A BR PI0509585A
Authority
BR
Brazil
Prior art keywords
drospirenone
skin
application
pharmaceutical preparation
preparation
Prior art date
Application number
BRPI0509585-9A
Other languages
English (en)
Inventor
Stefan Bracht
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of BRPI0509585A publication Critical patent/BRPI0509585A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PREPARAçãO FARMACêUTICA PARA A APLICAçãO NA PELE COM UM TEOR DE DROSPIRENONA. A presente invenção refere-se a uma preparação farmacêutica para a aplicação sobre a pele com um teor de drospirenona. Neste caso, a quantidade de drospirenona contida na preparação no estado de partida não está acima da solubilidade de saturação. No entanto, após a aplicação da preparação sobre a pele, a solubilidade de saturação da drospirenona é ultrapassada. Essa preparação farmacêutica possibilita, entre outros, a aplicação transdérmica de quantidades de drospirenona com efeito contraceptivo.
BRPI0509585-9A 2004-04-01 2005-03-19 preparação farmacêutica para a aplicação na pele com um teor de drospirenona BRPI0509585A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004016779A DE102004016779A1 (de) 2004-04-01 2004-04-01 Drospirenonhaltige Zubereitungen zur transdermalen Anwendung
PCT/EP2005/002971 WO2005097196A2 (de) 2004-04-01 2005-03-19 Pharmazeutische zubereitung zur applikation auf die haut mit einem gehalt an drospirenon

Publications (1)

Publication Number Publication Date
BRPI0509585A true BRPI0509585A (pt) 2007-10-09

Family

ID=34977050

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509585-9A BRPI0509585A (pt) 2004-04-01 2005-03-19 preparação farmacêutica para a aplicação na pele com um teor de drospirenona

Country Status (17)

Country Link
EP (1) EP1729778B1 (pt)
JP (1) JP2007530615A (pt)
KR (1) KR100832157B1 (pt)
CN (1) CN1933843A (pt)
AT (1) ATE397935T1 (pt)
AU (1) AU2005231582A1 (pt)
BR (1) BRPI0509585A (pt)
CA (1) CA2558349A1 (pt)
CR (1) CR8632A (pt)
DE (2) DE102004016779A1 (pt)
EA (1) EA200601818A1 (pt)
EC (1) ECSP066900A (pt)
ES (1) ES2307154T3 (pt)
IL (1) IL177938A0 (pt)
NO (1) NO20064978L (pt)
WO (1) WO2005097196A2 (pt)
ZA (1) ZA200609079B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2614187A1 (en) * 2005-07-15 2007-01-25 Bayer Schering Pharma Aktiengesellschaft Drospirenone containing transdermal drug delivery devices and methods of delivery thereof
WO2010008600A1 (en) * 2008-07-16 2010-01-21 Dermworx Incorporated Topical drug delivery system
US9241944B2 (en) 2010-06-16 2016-01-26 Institut National De La Santé Et De La Recherche Médicale (Inserm) Methods and compositions for stimulating reepithelialisation during wound healing
CN108606963B (zh) * 2017-12-27 2021-05-18 上海长海医院 含有屈螺酮和雌激素的复方避孕贴、制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU610839B2 (en) * 1986-11-07 1991-05-30 Purepac, Inc Transdermal administration of amines
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
DE19651000A1 (de) * 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
KR20040104632A (ko) * 2002-04-26 2004-12-10 쉐링 악티엔게젤샤프트 호르몬 대체 요법을 받는 여성에서 고혈압의 치료

Also Published As

Publication number Publication date
ZA200609079B (en) 2009-04-29
ES2307154T3 (es) 2008-11-16
JP2007530615A (ja) 2007-11-01
CA2558349A1 (en) 2005-10-20
IL177938A0 (en) 2006-12-31
CR8632A (es) 2007-06-06
EP1729778A2 (de) 2006-12-13
NO20064978L (no) 2006-10-31
WO2005097196A3 (de) 2006-06-01
ATE397935T1 (de) 2008-07-15
ECSP066900A (es) 2006-12-20
EA200601818A1 (ru) 2007-04-27
EP1729778B1 (de) 2008-06-11
DE102004016779A1 (de) 2006-01-19
KR20060132983A (ko) 2006-12-22
DE502005004403D1 (de) 2008-07-24
AU2005231582A1 (en) 2005-10-20
KR100832157B1 (ko) 2008-05-23
WO2005097196A2 (de) 2005-10-20
CN1933843A (zh) 2007-03-21

Similar Documents

Publication Publication Date Title
BR0209782A (pt) Kit para tratamento da pele
BR112012015696A2 (pt) composição líquida anídrica antitranspirante/desodorante
UY31080A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis
GT200600194A (es) Composiciones farmaceuticas conteniendo imatinib y un componente de liberacion prolongada
CL2008000593A1 (es) Uso de compuestos derivados de heterociclos sustituidos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad aterosclerotica de las arterias entre otras enfermedades.
BRPI0508540A (pt) composto, composição farmacêutica, e, uso de um composto
AR068369A1 (es) Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina"
CL2007003640A1 (es) Compuestos derivados de benzamida; composicion farmaceutica que comprende dichos compuestos; y su uso para el tratamiento en que la afeccion es dolor, tales como dolor lumbar y cervical, migrana, dismenorrea, dolor de muelas, entre otros.
CL2009000967A1 (es) Compuesto 4-ciclobutil-n-((2s,5r)-5-hidroxi-2-adamantil)-2-morfolin-4-ilpiridin-5-carboxamida, inhibidor de la enzima 11betahsd1; composicion farmaceutica que lo comprende; y su uso en un procedimiento de tratamiento profilactico o terapeutico de un animal de sangre caliente.
GT200400126A (es) Compuestos activos antitranspirantes de aluminio/zirconio/glicina, estabilizados con betaina
CL2008000594A1 (es) Uso de compuestos derivados de heterociclos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad arterial coronaria entre otras enfermedades.
BRPI0618239A8 (pt) uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusicos
UY31079A1 (es) Derivados de fenilaminobenceno sustituidos de utilidad para el tratamiento de trastornos y enfermedades hiperproliferativos asociados con actividad quinasa extracelular mediada por mitógenos
BR112020019875A8 (pt) composições tópicas para alívio da dor
CL2007003587A1 (es) Compuestos derivados de pirimidinas sustituidas; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para tratar o prevenir la infeccion de la hepatitis c.
DK1680128T3 (da) Myo-inositolhexaphosphat til topisk anvendelse
WO2010063030A3 (en) Dermal application of vasoconstrictors
BR112012015084A2 (pt) composição farmacêutica de liberação lenta de iloperidone
BRPI0916282B8 (pt) uso de um agonista do receptor-pgi2 no tratamento de insuficiência renal crônica
AR069223A1 (es) Combinacion antihelmintica
DK1414467T3 (da) Topisk behandling af mastalgi
BRPI0511209A (pt) composição farmacêutica e uso de uma associação de propionato de clobetasol e de calcitriol
BRPI0509585A (pt) preparação farmacêutica para a aplicação na pele com um teor de drospirenona
CL2007000765A1 (es) Combinaciones de principios activos que contienen al menos un compuesto derivado de pirazol carboxamida y otro principio activo; procedimiento de preparacion; procedimiento de aplicacion; y uso para combatir hongos fitopatogenos indeseados.
PE20061365A1 (es) Composiciones farmaceuticas de liberacion modificada

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.